BiotechTube
Home/Pipeline/Photosoft‑Skin

Photosoft‑Skin

Non‑melanoma Skin Cancer

Phase 1/2Active

Key Facts

Indication
Non‑melanoma Skin Cancer
Phase
Phase 1/2
Status
Active
Company
Invion

About Invion

Australianion leverages its Photosoft™ PDT platform to develop targeted, low‑toxicity cancer and disease therapies.

View full company profile

Therapeutic Areas

OncologyInfectious DiseasesDental/PeriodontalOphthalmology